Metoclopramide Injection, Solution
Product Images NDC 51662-1288

10 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Metoclopramide (NDC 51662-1288). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Boxed Warning (Boxed Warning)

Boxed Warning (Boxed Warning)
A text panel warning about tardive dyskinesia associated with metoclopramide treatment. It states that the movement disorder risk increases with treatment duration and dose, advises discontinuation if symptoms occur, and notes no known treatment for tardive dyskinesia. It recommends avoiding treatment longer than 12 weeks except in rare cases where benefits outweigh risks.*
FDA Label Image

Logo Spl (Logo Spl)

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of metoclopramide hydrochloride monohydrate showing its molecular formula, including a chlorine-substituted aromatic ring and functional groups. The image also states a molecular weight of 354.3.*
FDA Label Image

Clinical Tabel 1 (Clinical Pharm 1)

Clinical Tabel 1 (Clinical Pharm 1)
A pharmacokinetic data table listing parameters and values for metoclopramide. Parameters include volume of distribution (Vd) approximately 3.5 L/kg, plasma protein binding about 30%, half-life (t1/2) ranging from 5 to 6 hours, and oral bioavailability at 80% ± 15.5%.*
FDA Label Image

Clinical Tabel 2 (Clinical Pharm 2)

Clinical Tabel 2 (Clinical Pharm 2)
A pharmacokinetic data table for metoclopramide showing two references with dosing regimens, including IV administration routes, half-life (t1/2 in hours), clearance (Cl in L/hr/kg), volume of distribution (Vd in L/kg), and maximum concentration (Cmax in mcg/L). The table details values such as 0.35 mg/kg IV over 5 minutes and 2 mg/kg 30-minute IV infusions repeated 4 to 5 times over 9.5 hours.*
FDA Label Image
FDA Label Image

Rfid Label (51662 1288 1 Rfid)

Rfid Label (51662 1288 1 Rfid)
A product label for METOCLOPRAMIDE injection solution distributed by HF Acquisitions Co., LLC. The label includes GS1-style numeric codes and a datamatrix barcode, along with the text stating 'SEE MANUFACTURE'S INSERT' and the distributor's location in Mukilteo, WA 98275.*
FDA Label Image

Vial Pouch Label (51662 1288 2 Vial Pouch Label)

Vial Pouch Label (51662 1288 2 Vial Pouch Label)
METOCLOPRAMIDE Injection, USP 1 mg/2 mL (5 mg/mL) 2 mL vial label. The label shows the vial's NDC code 51662-1288-2, lot number, and storage instructions. It is a sterile, nonpyrogenic solution for intramuscular or intravenous use, with manufacturer HF Acquisition Co LLC, DBA HealthFirst, located in Mukilteo, WA.*
FDA Label Image

Case Label (51662 1288 3 Case Label)

Case Label (51662 1288 3 Case Label)
METOCLOPRAMIDE injection, 5 mg/mL in a 2 mL vial, labeled as USP 10 mg per 2 mL (5 mg per mL). The label includes the NDC 51662-1288-3 and the manufacturer is HF Acquisition Co LLC, DBA HealthFirst. It specifies the route of administration as intramuscular or intravenous and indicates the product is for prescription use only.*
FDA Label Image

Rfid Label (51662 1288 3 Rfid)

Rfid Label (51662 1288 3 Rfid)
Label of METOCLOPRAMIDE injection, solution 5 mg/mL by HF Acquisition Co LLC DBA HealthFirst. Shows barcodes, lot number, expiration date, and distribution information by HF Acquisitions Co., LLC in Mukilteo, WA. Label indicates prescription use only and advises to see the manufacturer's insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.